Michael E. Kamarck - 27 Oct 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Michael E. Kamarck, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
27 Oct 2021
Transactions value $
$0
Form type
4
Filing time
29 Oct 2021, 18:11:16 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +30,000 $0 30,000 27 Oct 2021 Common Stock 30,000 $22.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date